Strategy

Pharma has its sights on European academia

Read more

European biotechs post fourth annual advance

Read more

Pharma dealmaking has been smarter in 2015

Read more

Europe's new unitary patent

Read more

A US approach to value-based drug assessment

Read more

Innovation forces new thinking on drug pricing

Read more

A way forward for pricing new pharmaceuticals

Read more

Partnerships accelerate drug development

Read more

Finding new leads for Alzheimer's treatments

Read more

Humabs BioMedSA: Antibodies for infectious disease

Read more